Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model

被引:71
|
作者
Zhang, Sheng [5 ]
Feany, Mel B. [1 ]
Saraswati, Sudipta [3 ,4 ]
Littleton, J. Troy [3 ,4 ]
Perrimon, Norbert [2 ,5 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA
[3] MIT, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA
[4] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Genet, Boston, MA 02115 USA
关键词
AXONAL-TRANSPORT; INTERACTING PROTEIN; SYNAPTIC GROWTH; NEURODEGENERATIVE DISEASES; TARGETED DISRUPTION; EMBRYONIC LETHALITY; MUTANT HUNTINGTIN; GENE HOMOLOG; POLYGLUTAMINE; LOCALIZATION;
D O I
10.1242/dmm.000653
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A polyglutamine expansion in the huntingtin (HTT) gene causes neurodegeneration in Huntington's disease (HD), but the in vivo function of the native protein (Htt) is largely unknown. Numerous biochemical and in vitro studies have suggested a role for Htt in neuronal development, synaptic function and axonal trafficking. To test these models, we generated a null mutant in the putative Drosophila HTT homolog (htt, hereafter referred to as dhtt) and, surprisingly, found that dhtt mutant animals are viable with no obvious developmental defects. Instead, dhtt is required for maintaining the mobility and long-term survival of adult animals, and for modulating axonal terminal complexity in the adult brain. Furthermore, removing endogenous dhtt significantly accelerates the neurodegenerative phenotype associated with a Drosophila model of polyglutamine Htt toxicity (HD-Q93), providing in vivo evidence that disrupting the normal function of Htt might contribute to HD pathogenesis.
引用
收藏
页码:247 / 266
页数:20
相关论文
共 50 条
  • [21] Huntingtin and the molecular pathogenesis of Huntington's disease - Fourth in molecular medicine review series
    Landles, C
    Bates, GP
    EMBO REPORTS, 2004, 5 (10) : 958 - 963
  • [22] Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis
    Lee, C. Y. Daniel
    Cantle, Jeffrey P.
    Yang, X. William
    FEBS JOURNAL, 2013, 280 (18) : 4382 - 4394
  • [23] Long-term monitoring of the mortality trend of Huntington’s disease in Austria
    Eva Ekestern
    Gustav Lebhart
    European Journal of Epidemiology, 2005, 20 : 169 - 172
  • [24] Long-term effect of a single dose of flunarizine in Huntington's disease
    Belfiore, G
    Di Maio, L
    Napolitano, G
    Cella, S
    Filla, A
    De Michele, G
    Campanella, G
    EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 249 - 253
  • [25] Long-term monitoring of the mortality trend of Huntington's disease in Austria
    Ekestern, E
    Lebhart, G
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2005, 20 (02) : 169 - 172
  • [26] Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model
    Cheong, Rachel Y.
    Baldo, Barbara
    Sajjad, Muhammad U.
    Kirik, Deniz
    Petersen, Asa
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2021, 47 (04) : 564 - 578
  • [27] Mutant Huntingtin Affects Diabetes and Alzheimer's Markers in Human and Cell Models of Huntington's Disease
    Chaves, Gepoliano
    Stanley, John
    Pourmand, Nader
    CELLS, 2019, 8 (09)
  • [28] The Small House Model of Long-Term Care: Association With Older Adult Functioning
    Reinhardt, Joann P.
    Cimarolli, Verena R.
    Burack, Orah R.
    Minahan, Jillian
    Marshall, Tammy L.
    Weiner, Audrey S.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (02) : 222 - +
  • [29] Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease
    Arteaga-Bracho, Eduardo E.
    Gulinello, Maria
    Winchester, Michael L.
    Pichamoorthy, Nandini
    Petronglo, Jenna R.
    Zambrano, Alicia D.
    Inocencio, Julio
    De Jesus, Chirstopher D.
    Louie, Joseph O.
    Gokhan, Solen
    Mehler, Mark F.
    Molero, Aldrin E.
    NEUROBIOLOGY OF DISEASE, 2016, 96 : 144 - 155
  • [30] Long-term treatment of sleep breathing disorder in a patient with Huntington's disease
    Banno, K
    Hobson, DE
    Kryger, MH
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 261 - 264